## **Core Concept**
The secretion of Growth Hormone (GH) is regulated by various factors, including hypothalamic hormones and feedback mechanisms. GH plays a crucial role in growth, metabolism, and body composition. Its secretion is primarily controlled by two hypothalamic hormones: Growth Hormone-Releasing Hormone (GHRH) and Somatostatin (also known as Growth Hormone-Inhibiting Hormone, GH-IH).

## **Why the Correct Answer is Right**
Somatostatin, also known as Growth Hormone-Inhibiting Hormone (GH-IH), directly inhibits the secretion of Growth Hormone (GH) from the anterior pituitary gland. It acts through specific receptors on the surface of pituitary cells, leading to a decrease in GH release. This mechanism is crucial for the regulation of GH levels in the body, preventing excessive GH secretion.

## **Why Each Wrong Option is Incorrect**
- **Option A:** GHRH (Growth Hormone-Releasing Hormone) stimulates, rather than inhibits, GH secretion. It acts on the pituitary gland to increase the release of GH.
- **Option B:** This option might seem plausible due to the structure of the question, but without specific details on the option, we focus on the known physiology: Insulin-like Growth Factor 1 (IGF-1) provides negative feedback to the hypothalamus and pituitary gland, indirectly influencing GH secretion, but it is not a direct inhibitor like Somatostatin.
- **Option C:** If this option referred to a stimulatory factor or another regulatory element, it would be incorrect based on the direct action described for Somatostatin.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that Somatostatin and its analogs (like Octreotide) can be used therapeutically to manage conditions associated with excessive GH secretion, such as acromegaly. Understanding the inhibitory control of GH by Somatostatin is crucial for managing such endocrine disorders.

## **Correct Answer:** D. Somatostatin.